Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayes1, X Rabasseda, J R Prous

  • 1Prous Science, S.A., Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|July 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This guide provides an overview of recent clinical trials for a wide range of drugs, including novel cancer therapies and vaccines. Stay updated on the latest advancements in drug discovery and development through this comprehensive resource.

Area of Science:

  • Pharmacology and Therapeutics
  • Clinical Research and Drug Development
  • Oncology
  • Immunology
  • Vaccinology

Context:

  • Gateways to Clinical Trials serves as a comprehensive guide to the latest clinical trials.
  • Data is sourced from the Clinical Trials Knowledge Area of Prous Science Integrity, a drug discovery and development portal.
  • This issue highlights a diverse selection of pharmaceutical agents across various therapeutic areas.

Purpose:

  • To provide an up-to-date overview of ongoing and recently published clinical trials.
  • To facilitate access to information on novel drug candidates and established therapeutics in clinical development.
  • To support researchers, clinicians, and industry professionals in staying abreast of clinical research advancements.

Related Experiment Videos

Summary:

  • This compilation details clinical trial information for numerous drugs, including ABT-510, adalimumab, alefacept, alemtuzumab, AMG-531, anakinra, armodafinil, asenapine maleate, atazanavir sulfate, atorvastatin, Bortezomib, bosentan, CEB-1555, cetuximab, ciclesonide, clodronate, CT-011, Darifenacin hydrobromide, desloratadine, E-7010, ecallantide, eculizumab, efalizumab, eltrombopag, erlotinib hydrochloride, eslicarbazepine acetate, eszopiclone, ezetimibe, Febuxostat, fosamprenavir calcium, fulvestrant, Gefitinib, genistein, Haemophilus influenzae B vaccine, human papillomavirus vaccine, Imatinib mesylate, insulin glargine, Lenalidomide, liposomal cisplatin, MAb G250, mapatumumab, midostaurin, MP4, mycophenolic acid sodium salt, Natalizumab, neridronic acid, NSC-330507, Oblimersen sodium, ofatumumab, omalizumab, oral insulin, oregovomab, Paliperidone, parathyroid hormone (human recombinant), peginterferon alfa-2a, peginterferon alfa-2b, peginterferon alfa-2b/ribavirin, pegylated arginine deiminase 20000, pemetrexed disodium, pimecrolimus, pitavastatin, pneumococcal 7-valent conjugate vaccine, prasterone, pregabalin, pumosetrag hydrochloride, Recombinant malaria vaccine, retigabine, rivaroxaban, Ro-26-9228, romidepsin, rosuvastatin calcium, rotavirus vaccine, SGN-30, sitaxsentan sodium, solifenacin succinate, sorafenib, sunitinib malate, Tadalafil, tegaserod maleate, temsirolimus, TER-199, tifacogin, tiludronic acid, tiotropium bromide, Vildagliptin, VNP-40101M, vorinostat, YM-150, yttrium 90 (90Y) ibritumomab tiuxetan, Zanolimumab, and zoledronic acid monohydrate.
  • The information covers a broad spectrum of pharmaceutical agents, including targeted therapies, biologics, small molecules, and vaccines.
  • This resource aggregates data from recent literature and congresses, offering a snapshot of current clinical research.

Impact:

  • Provides critical intelligence for drug discovery and development professionals.
  • Facilitates informed decision-making in pharmaceutical research and clinical practice.
  • Contributes to the acceleration of therapeutic advancements by highlighting key clinical trial activities.